Molly Altman
Last active: 9/20/2016


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Suppression of the GTPase-activating protein RGS10 increases Rheb-GTP and mTOR signaling in ovarian cancer cells. Altman MK, Alshamrani AA, Jia W, Nguyen HT, Fambrough JM, Tran SK, Patel MB, Hoseinzadeh P, Beedle AM, Murph MM (2015) Cancer Lett 369(1): 175-83
    › Primary publication · 26319900 (PubMed) · PMC4654121 (PubMed Central)
  2. Vinyl sulfone analogs of lysophosphatidylcholine irreversibly inhibit autotaxin and prevent angiogenesis in melanoma. Murph MM, Jiang GW, Altman MK, Jia W, Nguyen DT, Fambrough JM, Hardman WJ, Nguyen HT, Tran SK, Alshamrani AA, Madan D, Zhang J, Prestwich GD (2015) Bioorg Med Chem 23(17): 5999-6013
    › Primary publication · 26190462 (PubMed) · PMC4554797 (PubMed Central)
  3. Regulator of G-Protein Signaling 5 Reduces HeyA8 Ovarian Cancer Cell Proliferation and Extends Survival in a Murine Tumor Model. Altman MK, Nguyen DT, Patel SB, Fambrough JM, Beedle AM, Hardman WJ, Murph MM (2012) Biochem Res Int : 518437
    › Primary publication · 22792465 (PubMed) · PMC3389655 (PubMed Central)
  4. MicroRNA-30c-2* expressed in ovarian cancer cells suppresses growth factor-induced cellular proliferation and downregulates the oncogene BCL9. Jia W, Eneh JO, Ratnaparkhe S, Altman MK, Murph MM (2011) Mol Cancer Res 9(12): 1732-45
    › Primary publication · 22024689 (PubMed)
  5. Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells. Hooks SB, Callihan P, Altman MK, Hurst JH, Ali MW, Murph MM (2010) Mol Cancer : 289
    › Primary publication · 21044322 (PubMed) · PMC2988731 (PubMed Central)
  6. Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid. Altman MK, Gopal V, Jia W, Yu S, Hall H, Mills GB, McGinnis AC, Bartlett MG, Jiang G, Madan D, Prestwich GD, Xu Y, Davies MA, Murph MM (2010) Mol Cancer : 140
    › Primary publication · 20529378 (PubMed) · PMC2895597 (PubMed Central)
  7. Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation. Pashuck TD, Franz SE, Altman MK, Wasserfall CH, Atkinson MA, Wronski TJ, Flotte TR, Stalvey MS (2009) Pediatr Res 65(3): 311-6
    › Primary publication · 19047917 (PubMed) · PMC4201032 (PubMed Central)
  8. Supraphysiological testosterone enanthate administration prevents bone loss and augments bone strength in gonadectomized male and female rats. Yarrow JF, Conover CF, Purandare AV, Bhakta AM, Zheng N, Conrad B, Altman MK, Franz SE, Wronski TJ, Borst SE (2008) Am J Physiol Endocrinol Metab 295(5): E1213-22
    › Primary publication · 18780767 (PubMed)